Michael Derek Roth

Title: Michael Derek Roth: Innovator in Biologic Agent Delivery

Introduction

Michael Derek Roth is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biologic agent delivery through his innovative patents. With a total of 2 patents, Roth's work focuses on enhancing the efficacy of biologic agents in medical applications.

Latest Patents

Roth's latest patents include "Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents." This invention discloses hyaluronic acid-based hydrogels and solutions that possess properties such as self-resorption and extended release of biologically active agents. These advancements aim to decrease degradation, denaturation, and functional inactivation of biologically active agents.

Another notable patent is "Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient." This invention provides methods to enhance the development of antigen-presenting cells (APC) from precursor cells by administering a combination of GM-CSF and IL-4. The methods described can be utilized as a form of cytokine immunotherapy, aiming to reduce tumor burden and induce antigen-specific immunity.

Career Highlights

Michael Derek Roth is affiliated with the University of California, where he continues to advance research in the field of biologic agents. His work has garnered attention for its potential impact on cancer treatment and immunotherapy.

Collaborations

Roth has collaborated with notable colleagues, including Robert Alan Figlin and Sylvia Marie Kiertscher, contributing to the advancement of research in his field.

Conclusion

Michael Derek Roth's innovative work in biologic agent delivery showcases his commitment to improving medical treatments. His patents reflect a deep understanding of the complexities involved in biologic applications, making him a valuable contributor to the field.